| Bourgeois et al. (2015) RCT | PLWD: n = 52 Mild to moderately severe AD (MMSE: 17.42 ± 3.77)
Trial and error learning (TE) (n = 21)
Errorless learning (n = 15)
Modeling with spaced retrieval (n = 16) | 6 weeks × 2 × 2 h | Cognitive rehabilitation PLWD trained on 3 IADLs based on interest and current task performance
TE: PLWD tries task independently, but mistakes are corrected and cues given.
EL: Giving instructions and cues before task execution to prevent mistakes made.
MR: Steps of task performed in front of PLWD, and recall of steps after delay
Conducted by: OTs | Measured at baseline, 1 week post-intervention, 4 weeks post-intervention
Primary outcomes
Participants' performance in IADL tasks: 3-point scale ranging from competence to deficit
Secondary outcomes
Cognition: MMSE BPSD: NPI | IADL task scores—Significant improvement in IADL score within group, no significant difference between groups. Participants' performances remained stable 1 month post-intervention.
Cognition, BPSD—No significant difference within and between groups |
| Callahan et al. (2017) RCT | Intervention: Occupational therapy + Collaborative Care (TAU) (N = 82)
Control: Collaborative Care (TAU) (N = 76) | Total duration: 24 months (18 home visits) Delivery and frequency: Cycle 1−8x 90 min session biweekly for 16 weeks Cycle 2−8x session every month for 32 weeks Cycle 3−8x session over 1 year | Intervention components: 1. Home modification and assessments 2. ADL and IADL training 3. Home exercise program 4. Caregiver education and training 5. Cognitive training 6. Phone calls
Conducted by: OTs and OTAs | Measured at baseline, 6, 12, 18, 24 months
Primary outcome
Functional status ADCS ADLa
Secondary outcomes
Physical performance SPPBb
Sarcopenia SPSMc | Functional status No significant difference
Physical performance and sarcopenia Progressive functional decline, decrease in SPPB and SPSM, and decline in mean MMSE scores across time |
| Clare et al. (2010) RCT | PLWD: n = 64 Caregivers: n = 44 Mild AD (MMSE: 23.14 ± 3.12) Stable dose of acetylcholinesterase-inhibitor for at least 4 weeks
Intervention Cognitive Rehabilitation (n = 20 PLWD, 13 caregivers) | 8 weeks × 1 × 60 min | Cognitive Rehabilitation: 1. Teaching practical aids and strategies. 2. Introducing methods to learn new information. 3. Practice on sustaining attention and concentration. 4. Stress management techniques. 5. Carers joined the last 15 min of session to support between-session implementation
Conducted by: 1. OTs 2. Caregivers conducted practice in between sessions | Measured at baseline, 8 weeks, 6 months post-intervention
Primary Outcome
Goal Performance and Satisfaction: COPM
Secondary Outcome
Cognition: RBMT-II, TEA. Verbal Fluency: TEA (Verbal fluency subtest). Functional Status: ILS (Health and Safety subtest), IADLS, PSMS. | Goal Performance and Satisfaction -Significant improvement in performance and satisfaction in CR group compared to NT and RT. Larger increase in performance noted for PLWD with caregivers involved in intervention.
PLWD anxiety and depressive symptoms—Significant decrease within CR group, but no significant difference between all groups as decrease was seen in all groups |
| Comparison 1 Relaxation (n = 21 PLWD, 8 caregivers)
Comparison 2 No treatment (n = 23 PLWD, 7 caregivers) | | | PLWD anxiety and depressive symptoms: HADS Quality of Life of PLWD: QOL-AD
Caregiver Mood: HADS Caregiver QOL: WHOQOL-BREF
Caregiver wellbeing: GHQ-12 Caregiver Burden: RSS
Memory awareness: MARS (Memory Functioning and Memory Performance subscales)
Brain activation: fMRI scan during face-name association task | Verbal fluency—Decrease within CR and RT groups, no significant difference between groups
Caregiver QOL—Significant improvement in WHOQOL-BREF (social relationships) within CR group. CR and RT scores significantly different to NT group, which had decline in scores
Cognition, functional status, QOL of PLWD caregiver mood, caregiver burden, caregiver wellbeing—No significant difference within and between groups
Memory awareness—No significant difference within CR group, but significantly better compared to NT
Brain activation—Greater brain activation during encoding and recognition in face-name tasks in CR group than controls from RT and NT |
| Dooley and Hinojosa (2004) Quasi-experimental | N = 40 dyads No mention of group sample size.
Intervention: Individualized occupational therapy home visits with suggestions based on Assessment of Instrumental Function (AIF) results
Control: Mailed report with suggestions from AIF results | Intervention group: 2 visits (1 assessment visit to provide recommendations + 1 follow-up 30 min visit) Frequency ranged from 1 to 6 months across participants with an average of 2.33 months follow-up | Recommendation of strategies to caregiver: Environmental modifications Strategies for caregiver to improve ADL performance Community-based assistance
Conducted by: OTs | Measured at baseline and follow-up
PLWD's Quality of Life (QOL)
Positive Affect and Activity Frequency: Affect and Activity Limitation- Alzheimer's Disease Assessment (AAL-ADD)
Self-care status: Physical Self-Maintenance Scale
Caregiver burden Zarit Burden Interview | QOL Significant improvement in aspects of positive affect, activity frequency and self-care status as compared to control
Caregiver burden Significantly lower as compared to control |
| Gitlin et al. (2018) RCT | N = 160 dyads Diagnosis of dementia (MMSE: 16.6 ± 7.8)
Intervention Tailored Activity Program (n = 76 dyads)
Control Phone-based caregiver education, with no discussion of activity or behavioral symptoms (n = 84 dyads) | 4 N (8 sessions, no mention on frequency or duration) | Tailored Activity Program (1) Assessment on PLWD and caregiver capabilities, routines, interests, environment (2) Activity prescription with goals, environment set-up, strategies for implementation and grading. (3) Caregiver education on using activities, handling distress and managing behavioral symptoms (4) Caregiver training on activity simplification and strategies for other care challenges
Conducted by: OTs | Measured at baseline, 4, 8 months
Primary outcome
BPSD: NPI-C
Secondary outcomes
Functional dependence: CAFU Pain during activities: Pain Intensity Scale. Affect of PLWD: 6 quality of life items on a 5-point scale. Caregiver depression: CES-D. Caregiver burden: ZB (SF). Time spent caregiving: Number of hours providing ADL/IADL assistance, doing things for PLWD in 24-h day | BPSD—Significant reduction in number, and frequency × severity of BPSD symptoms within TAP group, and compared to control group
Functional dependence No significant decrease in number of activities assisted within group, Significant difference between groups as control group had greater increase
Pain during activities—No significant pain reduction within group, significant difference between groups as control had increase in pain
Caregiver distress—Significant decrease in behavior-related distress, compared to control
Time spent caregiving—No significant decline in time spent within and between groups
PLWD affect, caregiver depression, burden—No significant difference within and between groups |
| Gitlin et al. (2008) RCT | N = 56 dyads Diagnosed wth Dementia (MMSE: 11.6 ± 8.1)
Intervention TAP (n = 27 dyads)
Control Waitlist (n = 29 dyads) | 4 months 8 sessions−6 × 90 min home visit 2 × 15 min telephone contact with OT | Tailored Activity Program (1) Assessments to understand routine, abilities, interests of PLWD, communication, home environment (2) Personalized activity plan with implementation techniques (3) Caregiver education on stress reduction strategies (4) Caregiver training on activity use, adjusting activity complexity and strategies for general care problems | Measured at baseline and 4 months
Primary outcomes
BPSD: Scale on number and frequency of 24 behaviors, compiled from ABDS, RMBPC, previous research and report of families. Mood: CSDD Activity Engagement: Caregiver report of patient in past two weeks. | BPSD—Significant decrease in frequency of BPSD symptoms of TAP group compared to control. Non-significant decrease in overall number of behaviors, despite significant decrease in agitation and argumentative behaviors in TAP group.
Activity engagement—Significant improvement in TAP group compared to control
QOL of PLWD—Non-significant improvement in QOL in TAP group compared to control |
| Conducted by: OTs 2. Caregivers conducted practice in between sessions | Quality of life: QOL-AD.
Secondary outcomes
Caregiver Burden: Subjective burden scale (upset with behaviors), Zarit Burden Scale, objective burden scale (time spent on PLWD matters). Caregiver Mood: CES-D. Caregiver self-efficacy: 5 item scale for confidence.
Caregiver Mastery: 5 item scale for mastery
Caregiver skill enhancement: TMSI | Caregiver burden—Significantly fewer hours spent (objective), no significant difference for subjective burden within and between groups
Mood—No significant difference within and between groups
Caregiver mastery, self-efficacy, skill enhancement—Significant improvement in TAP group over control
Caregiver mood—No significant difference between groups |
| Gitlin et al. (2010) RCT | n = 209 dyads Dementia MMSE: 13.4 ± 8.1
Intervention: COPE biobehavioral intervention (n = 102)
Control: Telephone calls with scripted questions on care challenges and strategies (n = 107) | 4 months (10 sessions) | Biobehavioral intervention (1) Assessment: capabilities and deficits of patients, home environment, concerns and communication of caregivers. (2) Caregiver education of dementia and PLWD's capabilities. (3) Caregiver training: Problem solving, communication, activity engagement, task simplification and caregiver stress reduction
Conducted by: 1. OTs 2. Advanced practice nurse | Measured at baseline, 4, 9 months
Patient outcomes
Functional dependence: FIM Patient's Quality of Life (perceived by caregiver: QOL-AD Activity engagement: 5-item scale. Agitated behaviors: ABID
Caregiver outcomes
Caregiver wellbeing: PCI Caregiver confidence: 5 investigator developed items. Challenging problems: Targeted measurement approach (9 months follow-up). Caregiver appraisal of study benefits: 11-item survey (9 months follow-up) | Functional dependence—Significant improvement in IADLs, non-significant improvement in ADLs between groups
Activity engagement—Significant improvement of COPE group over control group
QOL of PLWD, agitated behaviors—No significant difference between groups
Challenging problems−62.7% of COPE caregivers had 1 or more caregiver-identified problems eliminated in 4 months, compared to 44.9% in control group.
Caregiver wellbeing, confidence—Significant improvement in COPE group over control group
9-month follow up: No statistical difference for any outcome measure, but COPE group caregiver perceived more benefits of intervention |
| Graff et al. (2006) RCT | N = 135 dyads
Intervention: Occupational therapy (N = 68)
Control: No Occupational therapy (N = 67) | Intervention group: 10 × 60 min (across 5 weeks) | Intervention: Occupational Therapy—teaching participants strategies on how to cope with cognitive decline and teaching caregivers on strategies to manage and cope with their caregiving duties.
Conducted by: OTs | Measured at baseline, end-point (Week 6) and follow-up (Week 12)
Functional Status Assessment of motor and process skills (AMPS), Interview of deterioration of daily activities in dementia
Caregiver's burden/sense of competence Sense of competence questionnaire | Functional status Significant improvement in functional abilities as compared to control
Caregiver's burden/6 sense of competence Significant improvement as compared to control |
| Holden et al. (2019) Quasi-experimental | n = 11 dyads Dementia MOCA: 14.4 ± 7.8
Intervention: Neurologic music therapy (n = 11) | 6 weeks × 1 × 60–90 min | Neurologic music therapy (1) Musical sensory orientation training: sing and play-along with instrument. (2) Musical Attention Control Training: Sustained and selective attention music -based tasks (3) Associative mood and memory training: Music and memory reminiscence (4) Caregiver skills training on techniques for NMT, social and emotional interactions
Conducted by: Music therapist | Measured at baseline, 6, 12 weeks BPSD: NPI-C
Quality of life: QOL-AD Functional disability: DAD Caregiver burden: ZBI Caregiving self-efficacy: RSCSE | BPSD—Significant decrease in NPI score at 6 and 12 weeks from baseline
Caregiving self-efficacy—No significant overall difference. Deteriorated at 6 weeks but improved at 12 weeks
QOL, Functional disability, Caregiver burden—No significant difference |
| Laird et al. (2018) Quasi-experimental | N = 29 dyads (PLWDs: mild-moderate dementia)
Intervention: home-based personalized reminiscence using ipad app (Inspired) (N = 29)
No control group | Intervention: 19 weeks (5 training sessions + 12 weeks × 3) | Intervention: Files uploaded (photos, videos, audios) to view and access for reminiscence purposes
Conducted by: 1. Reminiscence trainer (training) 2. Trained caregivers | Measured at baseline, midpoint (Week 13) and closure (Week 19)
Primary outcomes
Mutuality Mutuality scale
Secondary outcomes
Relationship quality Quality of Care-Patient Relationship Scale (QCPR) | Mutuality PLWDs: Significant increase in scores Caregivers: No significant difference
Relationship quality PLWDs: Significant improvement Caregivers: No significant difference
Subjective wellbeing PLWDs: Significant improvement Caregivers: Non-statistically significant decrease |
| Subjective wellbeing World Health Organization-Five Wellbeing Index (WHO-5) | |
| Moniz-Cook et al. (1998) Quasi-Experiment | n = 30 PLWD, 20 caregivers Mild dementia MMSE: Not mentioned
Intervention Individualized psycho-education and memory rehabilitation (n = 15 PLWD, n = 10 caregiver)
Control Pamphlets on dementia care (n = 15 PLWD, n = 10 caregivers) | 4–14 weeks (total 6–12 h) | Psychoeducation by psychologist Information on dementia, crisis prevention, counseling, emphasis of tapping on remaining abilities and being socially active
Individualized memory rehabilitation by caregiver Use of psychological and practical techniques applied in daily tasks
Conducted by: Psychologist, caregiver | PLWD: Measured at baseline and 18 months later (follow-up) Caregivers: Measured at 6 and 18 months after diagnosis
Cognition: RBMT Caregiver Wellbeing: GHQ-30. Caregiver mood: BDI, HADS
Service usage: Recording service usage data | Cognition
– Non-significant improvement within experimental group, but significant difference compared to deterioration noted in control group.
Caregiver wellbeing and mood—Significant improvement within and between groups
Service usage
– Significant difference between groups |
| O'Connor et al. (2019) RCT | n = 20 dyads Frontotemporal dementia MOCA: 12.0 ± 15.5
Intervention TAP (n = 9 dyads) Control Phone call (n = 11 dyad) | 4 months (8 sessions) | Tailored Activity Program
Assessment on abilities and interests of PLWD. 2) Personalized activity plan 3) Caregiver education about dementia, activity use, managing behaviors and adapting to declining abilities of PLWD)
Conducted by: OTs | Measured at baseline, 4 months
BPSD: NPI-C Functional Status: DAD. Quality of life/wellbeing: EQ-5D. Caregiver Vigilance: Vigilance scale | BPSD—Significant decrease in BPSD in TAP group than in control group, although agitation significantly worsened in TAP group
Functional status—Significant improvement within and between groups
Quality of life, caregiver vigilance—No significant difference within and between groups |
| Onder et al. (2005) RCT | n = 137 dyads Alzheimer's Disease MMSE: 20.2 ± 3.3 Stable dose of cholinesterase inhibitors ≥3 months
Intervention Reality Orientation Program (n = 70) Control No treatment (n = 67) | 25 weeks × 3 × 30 min | Reality orientation programme (1) Orientating to personal factors, time and location. (2) Introducing general topics. (3) Cognitive exercises on attention, memory and visuospatial ability. (4) Caregivers engaged PLWD in informal reality-based communication during day
Conducted by: Caregivers | Measured at baseline and at 25 weeks post-intervention
Cognition: MMSE, ADAS-Cog Functional Status: BI, Lawton IADL scale BPSD: NPI
Caregiver Mood: HAS, HRSD Caregiver QOL: SF-36 Caregiver Burden: CBI | Cognition—Significant improvement in MMSE and ADAS-Cog within and between groups
BPSD, Functional status: No significant difference within and between groups
Caregiver mood, quality of life, burden—No significant difference within and between groups |
| Orgeta et al. (2015) RCT | n = 273 dyads Mild to moderate dementia MMSE: 21.23 ± 4.30
Intervention ICST (n = 134)
Control TAU, which varied between centers and over time (e.g., non CST-based group activities) (n = 139) | 25 weeks × 3 × 30 min | Individual Cognitive Stimulation Therapy (ICST) Each session consists of reality orientation, discussion of current events and the main ICST activity selected from two difficulty levels of cognitive demands
Conducted by: 1. Caregivers with support from researchers (telephone, 2x home visits) | Measured at baseline, 13 and 26 weeks
Primary outcomes
Cognition: ADAS-Cog. QOL of PLWD: QOL-AD. General health status of caregiver: SF-12
Secondary outcomes
Dementia-specific QOL: DEMQOL. BPSD: NPI. Functional ability: BADLS. Depressive symptoms of PLWD: GDS-15. Anxiety and depressive symptoms of caregiver: HADS. Quality of caregiving relationship: QCPR. Health-related QOL of CG: EQ-5D. Resilience: Resilience Scale (RS-14) | Cognition, QOL, ADLs, BPSD, depressive symptoms of PLWD—No significant difference between groups
Depressive and anxiety symptoms of caregiver, general health status of caregiver, resilience, caregiver distress—No significant difference between groups
Quality of caregiving relationship—Significant improvement from PLWD's perspective in ICST group over control group, but no significant difference from caregiver's perspective between groups
Health-related QOL of caregiver—Significant improvement of ICST group over control group |
| Orrell et al. (2017) RCT | n = 273 dyads Mild to moderate dementia MMSE: 21.12 ± 4.48
Intervention ICST (n = 134)
Control TAU, which varied between centers and over time (e.g., non-CST-based group activities) (n = 139) | 25 weeks × 3 × 30 min | Individual Cognitive Stimulation Therapy (ICST) Each session consists of reality orientation, discussion of current events and the main ICST activity selected from two difficulty levels of cognitive demands
Conducted by: Caregivers with support from researchers (telephone, 2x home visits) | Measured at baseline, 13 and 26 weeks
Primary outcomes
Cognition: ADAS-Cog. QOL of PLWD: QOL-AD. General health of caregiver: SF-12
Secondary outcomes
Dementia-specific QOL: DEMQOL. BPSD: NPI. Functional ability: BADLS. Depressive symptoms of PLWD: GDS-15. Anxiety and depressive symptoms of caregiver: HADS. Quality of caregiving relationship: QCPR. Health-related QOL of CG: EQ-5D. Resilience: Resilience Scale (RS-14) | Cognition, QOL, ADLs, BPSD, depressive symptoms of PLWD—No significant difference between groups
Depressive and anxiety symptoms of caregiver, general health status of caregiver, resilience, carer distress—No significant difference between groups
Quality of caregiving relationship—Significant improvement from PLWD's perspective in ICST group over control group, but no significant difference from caregiver's perspective between groups
Health-related QOL of caregiver—Significant improvement of ICST group over control group |
| Prick et al. (2016) RCT | n = 111 dyads Mild to moderate dementia MMSE: 21 ± 5.19
Intervention Multicomponent intervention (n = 57) Control Bulletins (n = 54) | 3 months (8 sessions) 1st month: 4 weeks × 60 min 2nd and 3rd month: 2 weeks × 60 minutes | Multi-component intervention Physical exercise. (2) Psycho-education. (3) Communication Skills training. (4) Pleasant activities training
Conducted by: 1. Research personnels 2. Caregivers (conduct homework activities between sessions) | Measured at baseline, 3 months (end-point), 6 months
Primary outcomes
Mood (Depression): CSDD, DRS-RAI-HC. Physical health: SF-36, SIP
Secondary outcomes
Behavioral disturbance: RMBPC | Mood—Significant increase in depressive symptoms compared to control (DRS-RAI-HC), no significant difference (CSDD). However, intervention participants expressed pleasure gained from intervention.
Behavioral disturbance—Increase at end-point and follow-up, compared to control
Physical health: No significant difference within and between groups |
| Prick et al. (2017) RCT | n = 111 dyads Mild to moderate dementia MMSE: 21 ± 5.19
Intervention Multicomponent intervention (n = 57) Control Bulletins (n = 54) | 3 months (8 sessions) 1st month: 4 weeks × 60 min 2nd and 3rd month: 2 weeks × 60 minutes | Multi-component intervention (1) Physical exercise. (2) Psycho-education. (3) Communication Skills training. (4) Pleasant activities training.
Conducted by: 1. Research personnel 2. Caregivers (conduct homework activities between sessions) | Measured at baseline, 3, 6 months
Cognition Memory: 8WT, RBMT. Executive function: WMS-R, BADS, GIT. Attention: WMS-R (Digit Span Test Forward subtest) | Attention—Small significant effect in intervention group over control group
Memory and executive function—No significant difference between groups |
| Thivierge et al. (2014) RCT | n = 17 PLWDs Mild to moderate AD MMSE: 21.56 ± 2.51
Intervention: Cognitive rehabilitation (n = 9)
Control: Waiting list (n = 8) | 4 weeks × 2 × 45–60 min | Cognitive rehabilitation: Train IADL based on dyad's needs and interests.
Errorless learning: Adjusting degrees of assistance given to reduce errors
Spaced retrieval: increase in delays given between correct realization of task
Conducted by: 1. Trained research personnel 2. Caregivers (conduct practices between sessions) | Measured at baseline, 5, 9, 13 weeks
Primary outcomes
IADL performance: DMT
Secondary outcomes
Cognitive status: DRS-2
Everyday memory function: RBMT
Behavioral symptoms: NPI
Functional disability: DAD Quality of Life: DEMQoL
Caregiver burden: ZBI-22 | IADL performance—Significant improvement within intervention group and over control group, maintained until follow-up at week 13.
Cognitive status, memory, behavioral symptoms, functional disability, QOL, caregiver burden—No significant difference within and between groups |